Tryptophan hydroxylase 2 aggregates through disulfide cross-linking upon oxidation: possible link to serotonin deficits and non-motor symptoms in Parkinson’s disease
Authors:
Open Access
- 24 November 2010
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 116 (3) , 426-437
Abstract
J. Neurochem. (2011) 116, 426–437. Abstract Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopamine neurons of the nigrostriatal system, resulting in severe motor disturbances. Although much less appreciated, non-motor symptoms are also very common in PD and many can be traced to serotonin neuronal deficits. Tryptophan hydroxylase (TPH) 2, the rate-limiting enzyme in the serotonin biosynthesis, is a phenotypic marker for serotonin neurons and is known to be extremely labile to oxidation. Therefore, the oxidative processes that prevail in PD could cause TPH2 misfolding and modify serotonin neuronal function much as is seen in dopamine neurons. Oxidation of TPH2 inhibits enzyme activity and leads to the formation of high molecular weight aggregates in a dithiothreitol-reversible manner. Cysteine-scanning mutagenesis shows that as long as a single cysteine residue (out of a total of 13 per monomer) remains in TPH2, it cross-links upon oxidation and only cysteine-less mutants are resistant to this effect. The effects of oxidants on TPH2 catalytic function and cross-linking are also observed in intact TPH2-expressing HEK293 cells. Oxidation shifts TPH2 from the soluble compartment into membrane fractions and large inclusion bodies. Sequential non-reducing/reducing 2-dimensional sodium dodecyl sulfate–polyacrylamide gel electrophoresis and immunoblotting confirmed that TPH2 was one of a small number of cytosolic proteins that form disulfide-bonded aggregates. The propensity of TPH2 to misfold upon oxidation of its cysteine residues is responsible for its catalytic lability and may be related to loss of serotonin neuronal function in PD and the emergence of non-motor (psychiatric) symptoms.Keywords
This publication has 80 references indexed in Scilit:
- Potential mechanisms underlying anxiety and depression in Parkinson's disease: Consequences of l-DOPA treatmentNeuroscience & Biobehavioral Reviews, 2011
- Mechanisms Underlying Inflammation in NeurodegenerationCell, 2010
- Nonmotor Symptoms of Parkinson's Disease Revealed in an Animal Model with Reduced Monoamine Storage CapacityJournal of Neuroscience, 2009
- The two faces of protein misfolding: gain‐ and loss‐of‐function in neurodegenerative diseasesThe EMBO Journal, 2008
- Cysteine 111 Affects Aggregation and Cytotoxicity of Mutant Cu,Zn-superoxide Dismutase Associated with Familial Amyotrophic Lateral SclerosisJournal of Biological Chemistry, 2008
- Stress, Protein (Mis)folding, and Signaling: The Redox ConnectionScience's STKE, 2004
- Phosphorylation and Activation of Tryptophan Hydroxylase by Exogenous Protein Kinase AJournal of Neurochemistry, 1996
- Immortalization of raphe neurons: an approach to neuronal function in vitro and in vivoJournal of Chemical Neuroanatomy, 1992
- Tryptophan hydroxylase activity in the brains of controls and parkinsonian patientsJournal of Neural Transmission, 1985
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976